Experimental UC drug trial halted early – what we know
Disease control
Terminated
This early-stage trial tested a new antibody drug (BB-TL1A-VIAL-HLE) in 16 healthy volunteers and people with moderate-to-severe ulcerative colitis. The goal was to check safety and see if it could improve colon inflammation. However, the study was terminated early, so we have li…
Phase: PHASE1 • Sponsor: Vial Australia Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC